Original Article
Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain
Análisis de coste-efectividad y coste-utilidad de ingenol mebutato versus diclofenaco 3% e imiquimod 5% en el tratamiento de la queratosis actínica en España
I. Elíasa, N. Ortega-Joaquína, P. de la Cuevab, L.J. del Pozoc, D. Moreno-Ramírezd, A. Boadae, M. Aguilarf, A. Miradag, E. Mosquerag, C. Gibbonsh, I. Oyagüeza,
Corresponding author
a Pharmacoeconomics & Outcomes Research Iberia, Madrid, Spain
b Departamento de Dermatología, Hospital Universitario Infanta Leonor, Madrid, Spain
c Departamento de Dermatología, Hospital Universitario Son Espases, Mallorca, Spain
d Departamento de Dermatología, Hospital Universitario Virgen de la Macarena, Sevilla, Spain
e Departamento de Dermatología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain
f Departamento de Dermatología, Hospital Costa del Sol, Marbella, Málaga, Spain
g Laboratorios LEO Pharma, S. A., Barcelona, Spain
h LEO Pharma, Berkshire, Reino Unido
Read
5973
Timeswas read the article
2213
Total PDF
3760
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 53 | 13 | 66 |
| 2024 November | 88 | 62 | 150 |
| 2024 October | 76 | 40 | 116 |
| 2024 September | 63 | 23 | 86 |
| 2024 August | 105 | 47 | 152 |
| 2024 July | 106 | 32 | 138 |
| 2024 June | 95 | 33 | 128 |
| 2024 May | 90 | 33 | 123 |
| 2024 April | 101 | 31 | 132 |
| 2024 March | 98 | 27 | 125 |
| 2024 February | 83 | 30 | 113 |
| 2024 January | 81 | 35 | 116 |
| 2023 December | 74 | 15 | 89 |
| 2023 November | 81 | 26 | 107 |
| 2023 October | 123 | 23 | 146 |
| 2023 September | 71 | 26 | 97 |
| 2023 August | 33 | 12 | 45 |
| 2023 July | 41 | 46 | 87 |
| 2023 June | 27 | 13 | 40 |
| 2023 May | 47 | 23 | 70 |
| 2023 April | 38 | 29 | 67 |
| 2023 March | 50 | 23 | 73 |
| 2023 February | 35 | 28 | 63 |
| 2023 January | 40 | 24 | 64 |
| 2022 December | 69 | 33 | 102 |
| 2022 November | 44 | 24 | 68 |
| 2022 October | 27 | 33 | 60 |
| 2022 September | 29 | 42 | 71 |
| 2022 August | 24 | 32 | 56 |
| 2022 July | 28 | 56 | 84 |
| 2022 June | 20 | 26 | 46 |
| 2022 May | 51 | 35 | 86 |
| 2022 April | 47 | 35 | 82 |
| 2022 March | 53 | 65 | 118 |
| 2022 February | 44 | 64 | 108 |
| 2022 January | 34 | 60 | 94 |
| 2021 December | 41 | 48 | 89 |
| 2021 November | 49 | 47 | 96 |
| 2021 October | 60 | 57 | 117 |
| 2021 September | 41 | 42 | 83 |
| 2021 August | 51 | 32 | 83 |
| 2021 July | 34 | 36 | 70 |
| 2021 June | 67 | 42 | 109 |
| 2021 May | 40 | 56 | 96 |
| 2021 April | 114 | 80 | 194 |
| 2021 March | 68 | 33 | 101 |
| 2021 February | 43 | 37 | 80 |
| 2021 January | 35 | 21 | 56 |
| 2020 December | 62 | 21 | 83 |
| 2020 November | 24 | 32 | 56 |
| 2020 October | 31 | 15 | 46 |
| 2020 September | 40 | 17 | 57 |
| 2020 August | 20 | 23 | 43 |
| 2020 July | 26 | 20 | 46 |
| 2020 June | 41 | 41 | 82 |
| 2020 May | 36 | 16 | 52 |
| 2020 April | 22 | 21 | 43 |
| 2020 March | 27 | 23 | 50 |
| 2020 February | 5 | 0 | 5 |
| 2019 April | 5 | 8 | 13 |
| 2019 March | 0 | 4 | 4 |
| 2019 February | 1 | 0 | 1 |
| 2019 January | 1 | 0 | 1 |
| 2018 December | 3 | 0 | 3 |
| 2018 November | 1 | 0 | 1 |
| 2018 October | 1 | 0 | 1 |
| 2018 September | 5 | 0 | 5 |
| 2018 February | 23 | 5 | 28 |
| 2018 January | 40 | 12 | 52 |
| 2017 December | 41 | 10 | 51 |
| 2017 November | 46 | 12 | 58 |
| 2017 October | 35 | 12 | 47 |
| 2017 September | 32 | 15 | 47 |
| 2017 August | 30 | 15 | 45 |
| 2017 July | 26 | 9 | 35 |
| 2017 June | 47 | 11 | 58 |
| 2017 May | 34 | 18 | 52 |
| 2017 April | 39 | 14 | 53 |
| 2017 March | 28 | 14 | 42 |
| 2017 February | 15 | 19 | 34 |
| 2017 January | 22 | 8 | 30 |
| 2016 December | 55 | 19 | 74 |
| 2016 November | 48 | 23 | 71 |
| 2016 October | 33 | 22 | 55 |
| 2016 July | 3 | 4 | 7 |
Show all
